NCT06739473RecruitingPhase 4
Total-body Glucose Utilization in Obesity
Source: ClinicalTrials.gov · Last updated 18 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
There are three goals for this study. One is to investigate how different emotions and exposure to cold affect blood flow in the body. The second aim is to study how insulin affects blood flow and tissue glucose uptake, and to study whether this effect is altered in obesity. Last, the study focuses on establishing the lowest dose of a PET radiotracer, oxygen-15 labelled water, that can be used in clinical studies with a new whole-body PET scanner.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 29 Sept 2024
- Start date
- 25 Jan 2023
- Primary completion date
- Dec 2024
- Lead sponsor
- Turku University Hospital
- Diseases
- Obesity
- NCT number
- NCT06739473
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 60
- From 25 Jan 2023 to the primary completion date, Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- In the group with obesity: current or previous use of GLP-1-agonists or insulin
- Previous participation in PET studies
- Previous significant exposure to radiation
Other illness
- In the lean group history of obesity or type 2 diabetes
- History of eating disorders
- Any other condition that in the opinion of the investigator could create a hazard to the subject safety, endanger the study procedures or interfere with the interpretation of study results
Other
- Smoking, use of narcotics, excessive use of alcohol
- Claustrophobia
- Active plans for concieving (both sexes)
Who the study is looking for
- Age 20-60 years
- BMI either 18.5-25 kg/m2 or above 30 kg/m2
- Use of hormonal contraception for women in child bearing age
Age in the registry: 20 years to 60 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Turku PET Centre Coordinator of this site? Confirm its status | Turku | Finland | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.